Mobile Menu - OpenMobile Menu - Closed

E&C Announces Hearing on ARPA-H and Accelerating Biomedical Research

Feb 1, 2022
Press Release

Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) and Health Subcommittee Chairwoman Anna G. Eshoo (D-CA) announced today that the Health Subcommittee will hold a hearing on Tuesday, February 8, at 10:30 a.m. (EST) in the John D. Dingell Room, 2123 of the Rayburn House Office Building on the proposed Advanced Research Projects Agency for Health (ARPA-H) and accelerating biomedical research. The hearing is entitled, “ARPA-H: The Next Frontier of Biomedical Research.” 

“The historic development of the COVID-19 vaccines has demonstrated the vital importance of cutting-edge biomedical advancements, but we are only at the cusp of the promise ahead,” Pallone and Eshoo said. “President Biden’s bold proposal to create ARPA-H to exclusively drive biomedical breakthroughs has the potential to transform medicine. We look forward to hearing from the Director of the White House Office of Science and Technology Policy, Dr. Eric S. Lander, as well as experts in the field of biomedicine and advanced research. This hearing is a critical step as the Committee takes up the task of establishing ARPA-H and fulfilling the promise of this agency.”

This will be a hybrid hearing that includes both in person and remote member attendance via Cisco Webex video conferencing. Members of the public may view the hearing via live webcast accessible on the Energy and Commerce Committee’s website. Please note the webcast will not be available until the hearing begins.

The Committee strongly recommends that members of the media view the proceedings remotely. The Capitol and House Office Buildings currently have restricted access. Seating in the Committee room for credentialed media is very limited. Media must RSVP to their respective press gallery no later than 5 p.m. on Monday, February 7.  

House Radio/TV Gallery:


House Periodical Gallery:


House Daily Press Gallery:


Photographer Gallery:


Information for this hearing, including the Committee Memorandum, witnesses, testimony, and a live webcast will be posted HERE as they become available.